Lifang Guo

5PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 05, 2021
Prognostic significance of CTNNB1 mutation in recurrence of sporadic desmoid tumors.

Lifang Guo, Xin Wang, Benshan Xu

|Jun 21, 2020
Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters.

Zirui Wan, Lifang Guo, Pengfei Li

|Jul 07, 2019
Biophysical and biological characterization of PEGylated recombinant human endostatin.

Lifang Guo, Benshan Xu, Daifu Zhou

|May 03, 2019
Blockade of angiogenin by thalidomide inhibits the tumorigenesis of murine hemangioendothelioma.

Lifang Guo, Zirui Wan, Benshan Xu

|Dec 12, 2018
Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M2 ES).

Lifang Guo, Xingchao Geng, Li Liu

Pageof 1

Frequent Collaborators